Jazz Pharmaceuticals PLC JAZZ:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:08 PM EDT
110.12quote price arrow up+0.11 (+0.10%)
Volume
8,534
Close
110.01quote price arrow up+0.72 (+0.66%)
Volume
684,295
52 week range
103.01 - 146.70
Loading...
  • Open110.14
  • Day High111.55
  • Day Low108.58
  • Prev Close109.29
  • 52 Week High146.70
  • 52 Week High Date08/31/23
  • 52 Week Low103.01
  • 52 Week Low Date05/02/24

Key Stats

  • Market Cap6.859B
  • Shares Out62.35M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta0.64
  • YTD % Change-10.56

KEY STATS

  • Open110.14
  • Day High111.55
  • Day Low108.58
  • Prev Close109.29
  • 52 Week High146.70
  • 52 Week High Date08/31/23
  • 52 Week Low103.01
  • 52 Week Low Date05/02/24
  • Market Cap6.859B
  • Shares Out62.35M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta0.64
  • YTD % Change-10.56

RATIOS/PROFITABILITY

  • EPS (TTM)4.85
  • P/E (TTM)22.70
  • Fwd P/E (NTM)5.54
  • EBITDA (TTM)1.156B
  • ROE (TTM)9.41%
  • Revenue (TTM)3.843B
  • Gross Margin (TTM)89.53%
  • Net Margin (TTM)8.69%
  • Debt To Equity (MRQ)154.49%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Jazz Pharmaceuticals PLC

Profile

MORE
Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Company’s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Defitelio (defibrotide sodium) AND Vyxeos (daunorubicin and...
Bruce Cozadd
Chairman of the Board, Chief Executive Officer
Renee Gala
President, Chief Operating Officer
Philip Johnson
Chief Financial Officer, Executive Vice President
Neena Patil J.D.
Executive Vice President, Chief Legal Officer
Robert Iannone M.D.
Executive Vice President, Global Head of Research and Development
Address
Fifth Fl
Waterloo Exchange, Waterloo Road
Dublin
4
Ireland